ASCO

CRO

ASCO, Ryght AI team up for breast cancer trial site selection

ASCO and RyghtAI are teaming up to identify research sites for trials evaluating doses of CDK4/6 inhibitors in patients with metastatic breast cancer.

Will Maddox Jun 1, 2026 2:00pm

cancer target detection radiopharma radio

ASCO: Kura, Kyowa reveal 23% remission rate behind leukemia win

Jun 2, 2025 5:36pm

Bicara CEO: ASCO data resonate more with 'people that matter'

Jun 2, 2025 4:26pm

At ASCO, execs see chance to ‘rewrite textbooks’ in cancer care

Jun 2, 2025 9:45am

ASCO: Chasing Merus, Bicara shares 2-year HNSCC survival data

Jun 1, 2025 3:36pm

ASCO: Kite's CAR-T flies high in phase 1 B-cell lymphoma study

May 31, 2025 7:00pm